Skip to main content
. 2018 May 10;34(7):1299–1309. doi: 10.1007/s00381-018-3821-y

Table 1.

Summary of selected manuscripts reporting robot-assisted brain biopsy. “Pt” means patient. “Not reported” signifies that the authors do not make mention of this in the manuscript, whilst “None reported” signifies that the authors state this outcome did not occur within the study

Author (year)
City/state, country
Study design (level of evidence*) Number of patients
Age and sex
Robot Diagnostic biopsy rate Accuracy Complications Other
Kwoh (1988)
California, USA
Case report
(level 4)
1 pt
52-year-old male
Unimation Puma 200 robot 1/1 (100%) None reported None reported
Glauser (1995)
Lausanne, Switzerland
Case series
(level 4)
8 pts Minerva robot 6/8 (75%) 0.1–0.5 mm None reported Use of robot aborted in one operation owing to geometric inaccessibility
Willems (2003)
Utrecht, the Netherlands
Case series
(level 4)
23 pts
Median 53 years (range 22–74 years)
14 female and 9 male
MKM robot with instrument holder 22/23 (96%) 3.3 ± 1.7 mm using bone screws
4.5 ± 2 mm using adhesive markers
2 pts with haematoma: 1 pt asymptomatic and 1 pt with transient worsening of neurological symptoms
1 pt with permanent worsening of neurological symptoms
Haegelen (2010)
Lille, France
Case series
(level 4)
15 pts
5 children and 10 adults
Neuromate robot 15/17 (88%) Not reported 3 pts with neurological symptoms: 2 pts transient and 1 permanent 2 pts had repeat biopsies
Bekelis (2012)
New Hampshire, USA
Case series
(level 4)
41 pts
Mean 60 years (range 33–87 years)
20 male and 21 female
SurgiScope robot 44/45 (98%) Not reported 5 pts with haematoma: 4 pts asymptomatic and 1 pt that required craniotomy 4 pts had repeat biopsies
Dellaretti (2012)
Lille, France
Cohort study
(level 4)
33 pts Neuromate robot Not reported Not reported Not reported Cohort compared 123 transfrontal and 19 transcerebellar approaches with no significant difference found
LeFranc (2015)
Amiens, France
Case series
(level 4)
100 pts
Median 59 years (range 7–86 years)
67 male and 33 female
ROSA robot 97/100 (97%) Not reported 6 pts with haematoma: 4 pts asymptomatic and 2 pts with transient neurological symptoms
6 pts with transient worsening of neurological symptoms
Grimm (2015)
Tuebingen and Mainz, Germany
Case series
(level 4)
37 pts
Range 15–83 years
20 male and 17 female
Renaissance robot 33/37 (89%) Not reported 9 pts with haematoma: 8 pts asymptomatic and 1 pt that required craniotomy
Coca (2016)
Strasbourg, France
Case series
(level 4)
5 pts
Mean 9 years (range 5–13 years)
3 male and 2 female
ROSA robot 5/5 (100%) Not reported 1 pt with transient perioperative bradycardia
Carai (2017)
Pavia, Italy
Case series
(level 4)
7 pts
Range 5–13 years
5 female and 2 male
ROSA robot 7/7 (100%) Considered accurate but quantitative data not reported 2 pts with transient worsening of neurological symptoms
De Benedictis (2017)
Parma, Italy
Case series
(level 4)
26 pts ROSA robot 25/26 (96%) Considered accurate but quantitative data not reported 2 pts with transient worsening of neurological symptoms
Quick-Weller
(2017)
Frankfurt, Germany
Case series
(level 4)
2 pts
4-year-old male and 12-year-old female
ROSA robot 2/2 (100%) Not reported None reported
Miller (2017)
Missouri, USA
Case series
(level 4)
6 pts
Average age 13 years
ROSA robot 6/6 (100%) Not reported None reported
Minchev (2017)
Vienna, Austria
Case series
(level 4)
17 pts iSYS1 16/17 (94%) Entry point error: median 1.3 mm (range 0.2–2.6 mm)
Target point error: median 0.9 mm (range 0.0–3.1 mm)
None reported Use of robot aborted in one operation as error in image registration
Dlaka (2017)
Zagreb, Croatia
Case report
(level 4)
1 pt
45 years old
RONNA G3 1/1 (100%) Entry point error: 2.2 mm
Target point error: 2.3 mm
None reported

*Oxford Centre for Evidence-based Medicine – Levels of Evidence (2009)